Inventor
MANGANO GIORGINA
IT24 patents
⚠️ This page may combine multiple inventors who share the name “MANGANO GIORGINA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ACRAF
10 patentsUS7919518B2Apr 5, 2011
1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40
ACRAF6 citations73
US8017644B2Sep 13, 2011
2-arylindole derivatives as nPGES-1 inhibitors
ACRAF3 citations61
US7879900B2Feb 1, 2011
3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof
ACRAF3 citations61
US10005730B2Jun 26, 2018
3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor
ACRAF0 citations51
US9655906B2May 23, 2017
Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it
ACRAF0 citations51
US8871948B2Oct 28, 2014
(Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
ACRAF0 citations50
US10640488B2May 5, 2020
Antibacterial compounds
ACRAF0 citations49
US10633366B2Apr 28, 2020
Antibacterial compounds
ACRAF0 citations49
US10369130B2Aug 6, 2019
Antibacterial compounds
ACRAF0 citations37
US10221144B2Mar 5, 2019
Antibacterial compounds having broad spectrum of activity
ACRAF0 citations36
GUGLIELMOTTI ANGELO
5 patentsUS8835481B2Sep 16, 2014
1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and P40
GUGLIELMOTTI ANGELO13 citations83
US8461194B2Jun 11, 2013
1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and P40
GUGLIELMOTTI ANGELO6 citations83
US8569297B2Oct 29, 2013
1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1 and CX3CR1
GUGLIELMOTTI ANGELO2 citations62
US8314099B2Nov 20, 2012
1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1 and CX3CR1
GUGLIELMOTTI ANGELO5 citations62
US8283348B2Oct 9, 2012
1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40
GUGLIELMOTTI ANGELO4 citations61
ALISI MARIA ALESSANDRA
4 patentsUS9120801B2Sep 1, 2015
Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it
ALISI MARIA ALESSANDRA15 citations82
US8399477B2Mar 19, 2013
(Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
ALISI MARIA ALESSANDRA10 citations82
US8207214B2Jun 26, 2012
3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof
ALISI MARIA ALESSANDRA3 citations61
US8637682B2Jan 28, 2014
3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor
ALISI MARIA ALESSANDRA0 citations50
AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO—A C R A F S P A
2 patentsUS12377035B2Aug 5, 2025
Peptides for inhibiting cholinergic calcitonin gene-related peptide (CGRP) and acetylcholine (ACH) release or inhibiting sensitization-mediated by TRPV1-mediated excitability in sensory neurons and methods of use thereof
AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO—A C R A F S P A0 citations52
US12102705B2Oct 1, 2024
Peptides having inhibitory activity on muscarinic receptor M3
AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO—A C R A F S P A0 citations52
AZIENDE CHIM RIUN ANG FRANC A C R A F S P A
2 patentsUS9255073B2Feb 9, 2016
1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40
AZIENDE CHIM RIUN ANG FRANC A C R A F S P A0 citations47
US9249097B2Feb 2, 2016
3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor
AZIENDE CHIM RIUN ANG FRANC A C R A F S P A0 citations45